Application of Plasma ctDNA Methylation Markers in Recurrence Detection and Prognostic Assessment Following Local Ablation for Non-Small Cell Lung Cancer

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: fa0f75c57bed967a5b744fc600a721c1b3e54905
First added on: Sep 12, 2026